Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results
- PMID: 1849504
- DOI: 10.1007/BF02337611
Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results
Abstract
In this preliminary trial we studied 29 patients with primary malignant glial tumors to investigate the effectiveness of cisplatin combined with etoposide on these tumors. Hyperfractionated radiation therapy was given in the course of chemotherapy. The time to tumor progression in these glioblastoma multiforme (GBM) patients encouraged us to continue this treatment in a phase III study.
Similar articles
-
Preliminary data by cis-platin and etoposide using in primary glioblastoma.J Neurosurg Sci. 1990 Jul-Dec;34(3-4):279-82. J Neurosurg Sci. 1990. PMID: 1965906
-
Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1179-85. doi: 10.1016/0360-3016(94)90326-3. Int J Radiat Oncol Biol Phys. 1994. PMID: 7961028 Clinical Trial.
-
Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.J Neurooncol. 2001 Jan;51(2):133-41. doi: 10.1023/a:1010621400203. J Neurooncol. 2001. PMID: 11386410 Clinical Trial.
-
[Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].Bull Cancer. 2001 Sep;88(9):871-6. Bull Cancer. 2001. PMID: 11604360 Review. French.
-
Chemotherapy of malignant gliomas: studies of the BTCG.Rev Neurol (Paris). 1992;148(6-7):428-34. Rev Neurol (Paris). 1992. PMID: 1448662 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical